Specnova Chooses Ashland to Distribute Tart Cherry Extract in the US (Nutraceutical Business Review)

Specnova Chooses Ashland to Distribute Tart Cherry Extract in the US

Ashland, a global leader in providing specialty chemical solutions to customers in a wide range of consumer and industrial markets, has signed an exclusive agreement with UF Innovate | The Hub resident client Specnova, a natural ingredients biotechnology company, that gives Ashland exclusive rights to distribute NordicCherry tart cherry extract in the US.

NordicCherry extract is made with whole fruit Prunus cerasus Stevnsbaer sour/tart cherries grown in Nordic countries and uses a gentle, clean, proprietary water extraction process that concentrates key polyphenol bioactives. The bioactives are protected in a plant-starch matrix by MatrixShield technology.

“We are thrilled to combine our small molecule discovery platform and deep expertise in natural product compounds with Ashland’s passion for solving and their long-standing specialty ingredients expertise and scale which is unmatched,” said Sebastian Balcombe, CEO and founder of Specnova. “Specnova’s research-supported ingredient combined with Ashland’s innovative and solution-based culture, breadth of capabilities in formula development, delivery systems, analytical chemistry, wide customer reach and more, gives us confidence that NordicCherry will propel to the top of the tart cherry and wellness market.”

Learn more about Specnova Chooses Ashland to Distribute Tart Cherry Extract in the US.